Responsibility in Drug Advertising Act of 2024

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 9142 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 9142 To amend the Federal Food, Drug, and Cosmetic Act to restrict direct- to-consumer drug advertising. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 25, 2024 Ms. DeLauro introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to restrict direct- to-consumer drug advertising. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Responsibility in Drug Advertising Act of 2024''. SEC. 2. DIRECT-TO-CONSUMER DRUG ADVERTISING. The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) is amended-- (1) in section 301 (21 U.S.C. 331), by adding at the end the following: ``(jjj) The conduct of direct-to-consumer advertising of a drug in violation of section 506M.''; and (2) in chapter V, by…